These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23118211)

  • 1. Are 25 antibodies better than 1?
    Cuker A
    Blood; 2012 Nov; 120(18):3627-8. PubMed ID: 23118211
    [No Abstract]   [Full Text] [Related]  

  • 2. Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.
    Robak T; Windyga J; Trelinski J; von Depka Prondzinski M; Giagounidis A; Doyen C; Janssens A; Alvarez-Román MT; Jarque I; Loscertales J; Rus GP; Hellmann A; Jêdrzejczak WW; Kuliczkowski K; Golubovic LM; Celeketic D; Cucuianu A; Gheorghita E; Lazaroiu M; Shpilberg O; Attias D; Karyagina E; Svetlana K; Vilchevska K; Cooper N; Talks K; Prabhu M; Sripada P; Bharadwaj TP; Næsted H; Skartved NJ; Frandsen TP; Flensburg MF; Andersen PS; Petersen J
    Blood; 2012 Nov; 120(18):3670-6. PubMed ID: 22915649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura.
    Fogarty PF; Seggewiss R; McCloskey DJ; Boss CA; Dunbar CE; Rick ME
    Haematologica; 2006 Feb; 91(2):277-8. PubMed ID: 16461323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura.
    Ojeda-Uribe M; Federici L; Wolf M; Coppo P; Veyradier A
    Transfusion; 2010 Mar; 50(3):733-5. PubMed ID: 20609201
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory autoimmune thrombocytopenic purpura treatment with Rituximab.
    Patel K; Berman J; Ferber A; Caro J
    Am J Hematol; 2001 May; 67(1):59-60. PubMed ID: 11279663
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of therapies for immune thrombocytopenic purpura.
    Bussel J; Tarantino M
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S1-2. PubMed ID: 16815344
    [No Abstract]   [Full Text] [Related]  

  • 7. An affordable Fc-receptor blockade method to treat patients with chronic refractory autoimmune thrombocytopenic purpura.
    Ruiz-Argüelles GJ; López-Martínez B; Flores-Martínez J; Ruiz-Argüelles A; Pérez-Romano B
    Haematologica; 2001 May; 86(5):552-3. PubMed ID: 11410427
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITP) of 10 years duration after only two infusions of rituximab.
    Cohen Y; Polliack A
    Hematol J; 2002; 3(1):61-2. PubMed ID: 11960398
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent advances in the treatment of idiopathic thrombocytopenic purpura].
    Kurata Y
    Rinsho Ketsueki; 2007 May; 48(5):355-62. PubMed ID: 17571579
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
    Moschovi M; Trimis G; Pergantou H; Platokouki H; Vrachnou E; Tzortzatou-Stathopoulou F
    J Paediatr Child Health; 2005 Jul; 41(7):384-6. PubMed ID: 16014149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.
    Taube T; Schmid H; Reinhard H; von Stackelberg A; Overberg US
    Haematologica; 2005 Feb; 90(2):281-3. PubMed ID: 15710595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
    Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
    Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
    Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R
    Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary hemorrhagic telangiectasia, idiopathic thrombocytopenic purpura, and chronic lymphocytic leukemia treated with rituximab.
    Choueiri T; Lichtin AE
    Am J Med; 2002 Dec; 113(8):700-1. PubMed ID: 12505128
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.
    Pohlen M; Sargin B; Zicholl S; Bisping G; Müller-Tidow C; Berdel WE; Mesters R; Koschmieder S
    Eur J Haematol; 2010 Apr; 84(4):362-4. PubMed ID: 20050881
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion.
    Sullivan HC; Arthur CM; Thompson L; Patel SR; Stowell SR; Hendrickson JE; Lazarus AH
    Transfusion; 2018 Feb; 58(2):542-544. PubMed ID: 29411397
    [No Abstract]   [Full Text] [Related]  

  • 17. Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia.
    Zaja F; Vianelli N; Battista M; Sperotto A; Patriarca F; Tomadini V; Filì C; Tani M; Baccarani M; Fanin R
    Exp Hematol; 2006 May; 34(5):571-2. PubMed ID: 16647558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Safety of monoclonal antibody anti-CD 20 in refractory thrombocytopenic idiopathic purpura].
    de Roux Serratrice C; Brandi Y; Caillères S; Brunel V; Allègre T; Blanc AP
    Rev Med Interne; 2002 Oct; 23(10):869-70. PubMed ID: 12428493
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab in children with idiopathic thrombocytopenic purpura: does it really work?
    Russo G; Licciardello M; La Spina M
    Eur J Pediatr; 2004 Sep; 163(9):569. PubMed ID: 15243812
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of recombinant activated factor VII (NovoSeven) in the treatment of a patient with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage].
    Vyhovs'ka IaI; Karol' IuS; Fedak LM; Tsytsyk OI
    Lik Sprava; 2004; (7):77-81. PubMed ID: 15724622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.